Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126589401 | 12658940 | 1 | I | 20160726 | 0 | 20160816 | 20160816 | DIR | 70.00 | YR | M | N | 217.00000 | LBS | 20160808 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126589401 | 12658940 | 1 | PS | LISINOPRIL 2.5MG TABS | LISINOPRIL | 1 | Oral | Y | D | 0 | 1 | DF | COATED TABLET | QD | |||||
| 126589401 | 12658940 | 2 | SS | PRINIVIL | LISINOPRIL | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 3 | SS | ZESTRIL | LISINOPRIL | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 5 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 9 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 10 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 11 | C | ROPINIROLE. | ROPINIROLE | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 12 | C | ALBUTEROL - IPRATROPIUM | 2 | 0 | |||||||||||||
| 126589401 | 12658940 | 13 | C | FLUTICASONE NASAL | FLUTICASONEFLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 14 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 15 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 16 | C | COLACE | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 17 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 18 | C | METHYL | 2 | 0 | |||||||||||||
| 126589401 | 12658940 | 20 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 0 | ||||||||||||
| 126589401 | 12658940 | 22 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126589401 | 12658940 | 1 | Renal failure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126589401 | 12658940 | LT |
| 126589401 | 12658940 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126589401 | 12658940 | Drug hypersensitivity | |
| 126589401 | 12658940 | Feeding disorder | |
| 126589401 | 12658940 | Fluid intake reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126589401 | 12658940 | 1 | 20160708 | 20160726 | 0 |